NCT06531486View on ClinicalTrials.gov

A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

August 30, 2027

Conditions
Solid TumorOvarian CancerBreast CancerEndometrial Cancer
Interventions
OTHER

XS-02 capsules

Upon completion of all screening visits, eligible patients will be treated with XS-02 capsules at the appropriate dose.

Sponsors
All Listed Sponsors
lead

NovaOnco Therapeutics Co., Ltd.

INDUSTRY